Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | STRO-001 |
Synonyms | |
Therapy Description |
STRO-001 is an anti-CD74 antibody in conjugation with a cytotoxic agent that may specifically target CD74-positive tumor cells (Blood 2016 128 (22):464, PMID: 30701025). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
STRO-001 | SP7675 | CD74 Antibody 3 | STRO-001 is an anti-CD74 antibody in conjugation with a cytotoxic agent that may specifically target CD74-positive tumor cells (Blood 2016 128 (22):464, PMID: 30701025). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT03424603 | Phase I | STRO-001 | Study of STRO-001, an Anti-CD74 Antibody Drug Conjugate, in Patients With Advanced B-Cell Malignancies | Completed | USA | 0 |